Alere acquires Arriva Medical for $65 million, plus stock

12/2/2011 | Clinica (subscription required)

Arriva Medical, which supplies blood glucose monitors and other diabetes testing devices to patients' homes, has been acquired by in vitro diagnostics firm Alere for $65 million in cash, plus 806,452 restricted company shares. The deal will allow Alere to expand its footprint in the point-of-care diabetes diagnostics arena.

View Full Article in:

Clinica (subscription required)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Global Counsel - Advertising and Promotions
Mylan Inc.
Washington, DC